Skip to content

Maternal Odor as a Developmental Care Intervention for Apnea of Prematurity

PRETERM YENİDOĞANLARDA ANNE KOKUSUNUN APNE GELİŞİMİNE, FİZYOLOJİK PARAMETRELERE VE KİLO ALIMINA ETKİSİ

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07689669
Acronym
MOCARE
Enrollment
60
Registered
2026-07-08
Start date
2022-11-01
Completion date
2023-06-01
Last updated
2026-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apnea of Prematurity, Prematurity

Keywords

Maternal odor, Apnea of prematurity, Preterm infant, Developmental care, Neonatal intensive care, Physiologic stability, Randomized controlled trial

Brief summary

Apnea of prematurity is one of the most common complications in preterm infants hospitalized in neonatal intensive care units. This randomized controlled trial was conducted to evaluate the effect of maternal odor exposure as a developmental care intervention on apnea frequency, physiological parameters, and growth outcomes in preterm infants. Sixty preterm infants were randomly assigned to either a maternal odor intervention group or a routine care control group. The intervention group received maternal odor using a cotton cloth carrying the mother's natural scent for five consecutive days. The primary outcome was the daily number of apnea episodes. Secondary outcomes included oxygen saturation, heart rate, respiratory rate, body temperature, weight, and head circumference.

Detailed description

Apnea of prematurity is a frequent complication of preterm birth and is associated with intermittent hypoxemia and adverse clinical outcomes. Developmental care interventions that provide familiar sensory stimulation may improve physiological stability in preterm infants. Maternal odor is a natural olfactory stimulus that may support autonomic regulation and respiratory stability through early sensory recognition. This single-center, parallel-group, randomized controlled trial evaluated the effectiveness of maternal odor exposure in preterm infants admitted to the neonatal intensive care unit. Sixty eligible preterm infants were randomly assigned in a 1:1 ratio to either a maternal odor intervention group or a routine care control group. Maternal odor was provided using a cotton cloth impregnated with the mother's natural body odor, positioned approximately 10-15 cm from the infant's head for five consecutive days and replaced every 8 hours. The primary outcome was the daily frequency of apnea episodes. Secondary outcomes included oxygen saturation (SpO₂), heart rate, respiratory rate, body temperature, weight, and head circumference. Outcomes were compared between groups to determine whether maternal odor exposure improves respiratory stability and physiological regulation in preterm infants.

Interventions

OTHERMaternal odor

Maternal odor exposure was provided using a cotton cloth carrying the mother's natural body odor. The cloth was placed approximately 10-15 cm from the infant's head during routine care for five consecutive days. The cloth was replaced every 8 hours to maintain the maternal odor.

Sponsors

Ankara Yildirim Beyazıt University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Blinding was not feasible because of the nature of the maternal odor intervention.

Intervention model description

Participants were randomly assigned 1:1 ratio to either a maternal odor intervention group or a routine care control group. The intervention group received maternal odor exposure for five consecutive days, while the control group received routine neonatal intensive care.

Eligibility

Sex/Gender
ALL
Age
5 Days to 28 Days
Healthy volunteers
No

Inclusion criteria

* Preterm infants born between 26 and 37 weeks of gestation * Birth weight between 1000 and 2500 g * Hospitalized in the neonatal intensive care unit for at least 5 days * Receiving oral or enteral feeding * Written informed consent obtained from parent(s) or legal guardian(s)

Exclusion criteria

* Endotracheal intubation, mechanical ventilation, or nasal continuous positive airway pressure * Receiving oxygen therapy * Congenital heart disease * Suspected or confirmed sepsis * Intracranial hemorrhage * Receiving analgesic, sedative, or muscle relaxant therapy * Previous surgical procedure * Development of a medical condition requiring withdrawal from the study or hospitalization for less than 5 days

Design outcomes

Primary

MeasureTime frameDescription
Frequency of Apnea EpisodesDaily for 5 consecutive daysNumber of apnea episodes experienced by preterm infants during the 5-day study period. Apnea episodes were recorded prospectively using the Premature Observation Form.

Secondary

MeasureTime frameDescription
Heart RateMeasured four times daily for 5 consecutive daysHeart rate (beasts per minute) recorded during the study period and compared between the intervention and control groups
Peripheral Oxygen SaturationMeasured four times daily for 5 consecutive daysPeripheral Oxygen Saturation (%) measured repeatedly during the study period and compared between the maternal odor and control groups.
Respiratory RateMeasured four times daily for 5 consecutive daysRespiratory rate (breaths per minute) recorded repeatedly during the study period and compared between the maternal odor and control groups.
Body TemperatureMeasured four times daily for 5 consecutive daysBody temperature recorded repeatedly during the study period and compared between the maternal odor and control groups.
Weight GainBaseline and Day 5Change in body weight (grams) from baseline to Day 5 and comparison between the maternal odor and control groups.
Head Circumference GrowthBaseline and Day 5Change in head cincumference (cm) from baseline to Day 5 and comparison between the maternal odor and control groups.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 9, 2026